of gene therapy, including innovative methods for treating spinal muscular atrophy.
It is known that a complete cure for Parkinson's disease is still impossible at present, so the treatments currently available are limited to slowing the progression of the disease and alleviating its symptoms.
Parkinson’s Foundation notes that around 30,000 new cases of the disease are diagnosed annually worldwide, and it expects the number of people affected to reach between 12 and 15 million by 2040.
In March 2025, the Russian Science Foundation announced the discovery of the enzyme “Cathepsin D”, which, contrary to expectations, did not contribute to the treatment of the disease, but rather increased its severity, as it stimulates the formation of amyloids, which are malformed proteins that play a key role in the development of both Parkinson’s disease and Alzheimer’s disease.
Parkinson's disease is an age-related neurodegenerative disorder characterized by impaired movement and cognitive changes, resulting from damage to nerve cells responsible for producing dopamine.
